Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Herve T. Kouekam, MSc
AstraZeneca, Canada
Disclosure(s): Cytel Inc. (contracted to AstraZeneca): Employee of Cytel Inc.
Poster(s):
(P-1969) Safety, Immunogenicity, and Pharmacokinetics of Repeat Dosing with AZD7442 (Tixagevimab/Cilgavimab): Final Analysis of the ENDURE Phase 2, Dose-Ranging Study in Immunocompromised Participants
Saturday, October 19, 2024
12:15 PM – 1:30 PM
US PT